Overview

Minocycline in Primary Sclerosing Cholangitis (PSC)

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see how safe and effective minocycline is in the treatment of Primary Sclerosing Cholangitis (PSC).
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Minocycline